PUBLISHER: The Business Research Company | PRODUCT CODE: 1945354
PUBLISHER: The Business Research Company | PRODUCT CODE: 1945354
An implantable insulin pump is a surgically placed device that delivers insulin directly into the peritoneal cavity, continuously adjusting doses according to the patient's needs to help maintain stable blood sugar levels and reduce diabetes-related complications compared to daily injections.
The main types of implantable insulin pumps include closed-loop insulin pumps and open-loop insulin pumps. Closed-loop insulin pumps, also referred to as artificial pancreas systems, are advanced devices that automatically manage blood glucose levels in individuals with diabetes. These pumps are used for applications such as type 1 diabetes and type 2 diabetes and are utilized by end users including hospitals and homecare settings.
Tariffs are impacting the implantable insulin pump market by increasing the cost of imported electronic components, sensors, and precision manufacturing equipment used in pump production. Closed-loop insulin pump systems and smart open-loop pumps are particularly impacted, with North America and Asia-Pacific regions facing higher device costs due to cross-border supply dependencies. These tariffs have contributed to elevated pricing and slower adoption in cost-sensitive markets. However, they have also encouraged local manufacturing, supply chain diversification, and innovation in cost-efficient implantable pump technologies.
The implantable insulin pump market research report is one of a series of new reports from The Business Research Company that provides implantable insulin pump market statistics, including implantable insulin pump industry global market size, regional shares, competitors with a implantable insulin pump market share, detailed implantable insulin pump market segments, market trends and opportunities, and any further data you may need to thrive in the implantable insulin pump industry. This implantable insulin pump market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The implantable insulin pump market size has grown strongly in recent years. It will grow from $3.88 billion in 2025 to $4.26 billion in 2026 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to increasing prevalence of type 1 diabetes, limitations of multiple daily insulin injections, early development of implantable pump technology, growing awareness of intensive insulin therapy, hospital-based diabetes management practices.
The implantable insulin pump market size is expected to see strong growth in the next few years. It will grow to $6.09 billion in 2030 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to rising adoption of automated insulin delivery systems, advancements in implantable medical device design, increasing demand for personalized diabetes care, expansion of home-based diabetes management, favorable reimbursement and regulatory support. Major trends in the forecast period include rising adoption of implantable insulin delivery systems, growing preference for closed-loop insulin pumps, improved glycemic control through continuous insulin infusion, increasing acceptance of long-term implantable diabetes devices, enhanced focus on patient convenience and therapy adherence.
The rise in diabetes incidence is increasingly supporting the expansion of the implantable insulin pump market going forward. Diabetes is a chronic condition in which the body struggles to regulate blood glucose levels due to insufficient insulin production or ineffective insulin utilization. The growing number of diabetes cases is linked to rising obesity rates, physical inactivity, unhealthy dietary habits, and aging populations. Implantable insulin pumps provide precise and continuous insulin delivery, helping stabilize blood glucose levels, reduce the frequency of injections, and improve overall diabetes management and patient quality of life. For example, in May 2024, according to Diabetes UK, a UK-based charity, more than 5.6 million people were living with diabetes in the UK, with 2022-23 figures showing an increase of 167,822 cases compared to the previous year. Consequently, the rising incidence of diabetes is reinforcing expansion within the implantable insulin pump market.
Leading companies in the implantable insulin pump market are increasingly forming strategic partnerships to develop high-concentration, thermostable insulin formulations for next-generation implantable pumps. For example, in May 2024, Arecor Therapeutics plc, a US-based biopharmaceutical company, partnered with Medtronic Diabetes, a US-based medical technology company, to develop a novel insulin formulation using Arecor's Arestat technology platform. This formulation is designed for patients with limited options under conventional insulin delivery and aims to improve outcomes by reducing pump maintenance, enabling hepatic absorption, expanding clinical use, and lowering healthcare costs.
In June 2024, Arecor Therapeutics plc, a UK-based biotechnology company, partnered with Medtronic plc to develop a high-concentration, thermostable insulin for Medtronic's advanced implantable insulin pump systems. This collaboration seeks to improve treatment options for diabetes patients requiring intensive insulin therapy. Medtronic plc is an Ireland-based manufacturer of implantable insulin pumps.
Major companies operating in the implantable insulin pump market are Sanofi S.A., Abbott Laboratories, Medtronic plc, Dexcom Inc., Insulet Corporation, Tandem Diabetes Care Inc., Ypsomed Holding AG, Air Liquide Healthcare Ltd., Diabeloop SA, Glooko Inc., ViCentra B.V., Bigfoot Biomedical Inc., Beta Bionics Inc., Senseonics Holdings Inc., INREDA DIABETIC B.V., TIDEPOOL Inc., Medtrum Technologies Inc., Sernova Corp., PhysioLogic Devices Inc., EOFLOW CO. LTD., CamDiab Ltd.
North America was the largest region in the implantable insulin pump market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the implantable insulin pump market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the implantable insulin pump market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The implantable insulin pump market consists of sales of pump devices, delivery catheters, control systems, and insulin reservoirs. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Implantable Insulin Pump Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses implantable insulin pump market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for implantable insulin pump ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The implantable insulin pump market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.